SMAD3 inhibitors (Monash University)

N/A

Report date: 2025/01/26 16:13:00
NME

Base Information

Drug NameSMAD3 inhibitors (Monash University)
Drug Alias NameJL-0365
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMothers against decapentaplegic homolog 3 inhibitors
TargetsMothers against decapentaplegic homolog 3
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMonash University
China Registration ClassN/A

Develop Information

Active CompaniesMonash University
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A